30 related articles for article (PubMed ID: 23370352)
1. Tanshinone sensitized the antitumor effects of irradiation on laryngeal cancer via JNK pathway.
Xu H; Hao YL; Xu LN; Chen L; Xu FW
Cancer Med; 2018 Oct; 7(10):5187-5193. PubMed ID: 30239172
[TBL] [Abstract][Full Text] [Related]
2. Study on optimisation of extraction process of tanshinone IIA and its mechanism of induction of gastric cancer SGC7901 cell apoptosis.
Hou J; He J; Jin X; Hu T; Zhang Y
Afr J Tradit Complement Altern Med; 2013; 10(6):456-8. PubMed ID: 24311868
[TBL] [Abstract][Full Text] [Related]
3. Tanshinone IIA ameliorates cisplatin-induced toxicology and cisplatin resistance via regulating SLC7A11 expression.
Qin H; Yuan Y; Yuan M; Yi S; Yang Y; Zhang Y
Environ Toxicol; 2024 Mar; 39(3):1429-1441. PubMed ID: 37987512
[TBL] [Abstract][Full Text] [Related]
4. Tanshinone-I for the treatment of uterine fibroids: Molecular docking, simulation, and density functional theory investigations.
Tiwari A; Tiwari V; Sharma A; Singh D; Singh Rawat M; Virmani T; Virmani R; Kumar G; Kumar M; Alhalmi A; Noman OM; Mothana RA; Alali M
Saudi Pharm J; 2023 Jun; 31(6):1061-1076. PubMed ID: 37250358
[TBL] [Abstract][Full Text] [Related]
5. Retracted: Tanshinone IIA May Inhibit Gastric Cancer via Affecting the Intestinal Microbiome.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9791064. PubMed ID: 38077876
[TBL] [Abstract][Full Text] [Related]
6. The mechanisms of tanshinone in the treatment of tumors.
Zhang P; Liu W; Wang Y
Front Pharmacol; 2023; 14():1282203. PubMed ID: 37964867
[TBL] [Abstract][Full Text] [Related]
7. Tanshinone IIA targeting cell signaling pathways: a plausible paradigm for cancer therapy.
Alam SSM; Samanta A; Uddin F; Ali S; Hoque M
Pharmacol Rep; 2023 Aug; 75(4):907-922. PubMed ID: 37440106
[TBL] [Abstract][Full Text] [Related]
8. Tanshinone I inhibited growth of human chronic myeloid leukemia cells via JNK/ERK mediated apoptotic pathways.
Sun S; Zhu L; Lai M; Cheng R; Ge Y
Braz J Med Biol Res; 2021; 54(8):e10685. PubMed ID: 34037092
[TBL] [Abstract][Full Text] [Related]
9. Tanshinone IIA: A Review of its Anticancer Effects.
Fang ZY; Zhang M; Liu JN; Zhao X; Zhang YQ; Fang L
Front Pharmacol; 2020; 11():611087. PubMed ID: 33597880
[TBL] [Abstract][Full Text] [Related]
10. Tanshinone IIA enhances the inhibitory effect of imatinib on proliferation and motility of acute leukemia cell line TIB‑152 in vivo and in vitro by inhibiting the PI3K/AKT/mTOR signaling pathway.
Teng Z; Xu S; Lei Q
Oncol Rep; 2020 Feb; 43(2):503-515. PubMed ID: 31894340
[TBL] [Abstract][Full Text] [Related]
11. Farnesiferol C Induces Apoptosis in Chronic Myelogenous Leukemia Cells as an Imatinib Sensitizer via Caspase Activation and HDAC (Histone Deacetylase) Inactivation.
Jung JH; Park JE; Sim DY; Im E; Park WY; Lee D; Shim BS; Kim SH
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31698777
[TBL] [Abstract][Full Text] [Related]
12. The anticancer mechanism investigation of Tanshinone II
Cao YF; Wang SF; Li X; Zhang YL; Qiao YJ
BMC Syst Biol; 2018 Oct; 12(1):90. PubMed ID: 30373594
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the spinal astrocytic JNK/MCP-1 pathway activation correlates with the analgesic effects of tanshinone IIA sulfonate in neuropathic pain.
Tang J; Zhu C; Li ZH; Liu XY; Sun SK; Zhang T; Luo ZJ; Zhang H; Li WY
J Neuroinflammation; 2015 Mar; 12():57. PubMed ID: 25889689
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis Induced by Tanshinone IIA and Cryptotanshinone Is Mediated by Distinct JAK/STAT3/5 and SHP1/2 Signaling in Chronic Myeloid Leukemia K562 Cells.
Jung JH; Kwon TR; Jeong SJ; Kim EO; Sohn EJ; Yun M; Kim SH
Evid Based Complement Alternat Med; 2013; 2013():805639. PubMed ID: 23878608
[TBL] [Abstract][Full Text] [Related]
15. Activation of c-Jun N-terminal kinase mediates tanshinone IIA-induced apoptosis in KBM-5 chronic myeloid leukemia cells.
Yun SM; Jeong SJ; Kim JH; Jung JH; Lee HJ; Sohn EJ; Lee MH; Kim SH
Biol Pharm Bull; 2013; 36(2):208-14. PubMed ID: 23370352
[TBL] [Abstract][Full Text] [Related]
16. Tanshinone IIA inhibits gastric carcinoma AGS cells through increasing p-p38, p-JNK and p53 but reducing p-ERK, CDC2 and cyclin B1 expression.
Su CC
Anticancer Res; 2014 Dec; 34(12):7097-110. PubMed ID: 25503137
[TBL] [Abstract][Full Text] [Related]
17. Tanshinone IIA induces mitochondria dependent apoptosis in prostate cancer cells in association with an inhibition of phosphoinositide 3-kinase/AKT pathway.
Won SH; Lee HJ; Jeong SJ; Lee HJ; Lee EO; Jung DB; Shin JM; Kwon TR; Yun SM; Lee MH; Choi SH; Lü J; Kim SH
Biol Pharm Bull; 2010; 33(11):1828-34. PubMed ID: 21048307
[TBL] [Abstract][Full Text] [Related]
18. Tanshinone IIA induces autophagic cell death via activation of AMPK and ERK and inhibition of mTOR and p70 S6K in KBM-5 leukemia cells.
Yun SM; Jung JH; Jeong SJ; Sohn EJ; Kim B; Kim SH
Phytother Res; 2014 Mar; 28(3):458-64. PubMed ID: 23813779
[TBL] [Abstract][Full Text] [Related]
19. Tanshinone IIA inhibits leukemia THP-1 cell growth by induction of apoptosis.
Liu JJ; Zhang Y; Lin DJ; Xiao RZ
Oncol Rep; 2009 Apr; 21(4):1075-81. PubMed ID: 19288011
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
